Молекулярная медицина
57 статей · 11 журналов
Журналы подкатегории (11)
- Vaccine: X · Elsevier (57)
- Advances in Biological Regulation · Elsevier (0)
- Biotechnology Journal · Wiley (0)
- Cell Stem Cell · Elsevier (0)
- Human Genetics and Genomics Advances · Elsevier (0)
- International Journal of Peptide Research and Therapeutics · Springer Nature (0)
- Journal of Cellular and Molecular Medicine · Wiley (0)
- LabMed Discovery · Elsevier (0)
- Mitochondrial Communications · Elsevier (0)
- Molecular Informatics · Wiley (0)
- Molecular Oncology · Wiley (0)
- Editorial Board
- Psychological and experiential drivers of vaccine confidence after compliance
- Integrating vaccine platforms and delivery routes to improve breadth of influenza immunity
- Measles seroepidemiology and risk factors for low seroprevalence among newborns and children in Nha Trang, Viet Nam
- Obstetrician and public health physician maternal influenza vaccination recommendation practices: a cross-sectional survey in Shenzhen, China
- A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan
- Long-term persistence of humoral immunity after SARS-CoV-2 mRNA booster vaccination in SARS-CoV-2-naïve individuals
- Hepatitis B vaccine-induced immunity among hill tribe and stateless children in northern Thailand
- Title: Modeling the population impact of rotavirus vaccination in Shanghai: An age-structured transmission analysis, 2015–2024
- Social media exposure and HPV vaccination uptake in Pakistan: A behavioral insights-informed campaign evaluation
- Timeliness of measles vaccination in selected districts of Oromia Region, Ethiopia – 2021
- Parameters affecting dengue virus replication in Vero cells
- Herpes zoster vaccine intention among patients with systemic lupus erythematosus: a health belief model–based cross-sectional study
- Age- and program-related heterogeneity in rubella IgG antibody titers among adults undergoing municipal antibody testing in Japan
- Bacillus Calmette-Guérin (BCG) vaccination: Reliability and accuracy of different sources of information in Quebec, Canada
- Erratum to “Measles seroepidemiology and risk factors for low seroprevalence among newborns and children in Nha Trang, Viet Nam” [Vaccine X 32 (2026) 100881]
- Corrigendum to “Association of body mass index with COVID-19 risk and vaccine effectiveness in children” [Vaccine: X 31 (2026) 100878]
- Corrigendum to “Twinning between national immunization technical advisory groups: an innovative approach to strengthening evidence-informed immunization policy in the Americas” [Vaccine: X 33 (2026) 100907]
- From development to global access: a landscape analysis and systematic review of traditional COVID-19 vaccines (2020–2024)
- Estimating natural boosting and attenuation after second vaccination for varicella among children under five years old at 60 Japanese nursery schools through 2025
- Germ-free embryonated eggs support enhanced yellow fever virus 17D vaccine production through reduced interferon-β responses
- Zero-dose childhood vaccination and associated factors in Ethiopia: A systematic review and meta-analysis
- Twinning between national immunization technical advisory groups: an innovative approach to strengthening evidence-informed immunization policy in the Americas
- Understanding the burden of invasive pneumococcal disease attributable to serotype 3 in older adults in Europe, the United States, and Australia, and the potential of MAPS technology-based pneumococcal vaccines
- Schistosome vaccine development: a comprehensive review of progress, challenges, and future directions
- Immunogenicity and protective efficacy of an experimental inactivated coxsackievirus B3 vaccine based on a new candidate epidemic strain
- Adjuvant prophylactic human papillomavirus (HPV) vaccination in patients treated for vulvar high-grade squamous intraepithelial lesions (vHSIL); a systematic review
- Disparities in maternal COVID-19 vaccine coverage in Nairobi, Kenya: Private versus public hospital
- Immunogenicity and safety of SARS-COV-2 recombinant protein subunit vaccine (INDOVAC) in west Sumatera Province adolescents: A phase 3, observer blind, randomized, active-controlled
- Opening the door: acceptability of a shared decision-making tool to support uptake of seasonal respiratory virus vaccines